Management of MANEC of the colon and rectum: A comprehensive review of the literature

Paspala,Anna; Machairas,Nikolaos; Prodromidou,Anastasia; Spartalis,Eleftherios; Ioannidis,Argyrios; Kostakis,Ioannis  D.; Papaconstantinou,Dimetrios; Nikiteas,Nikolaos

doi:10.3892/mco.2018.1649

Management of MANEC of the colon and rectum: A comprehensive review of the literature

Authors:
- Anna Paspala
- Nikolaos Machairas
- Anastasia Prodromidou
- Eleftherios Spartalis
- Argyrios Ioannidis
- Ioannis D. Kostakis
- Dimetrios Papaconstantinou
- Nikolaos Nikiteas
View Affiliations

Affiliations: Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece, Second Department of General Surgery, ‘Sismanoglio’ General Hospital, 15126 Athens, Greece
Published online on: June 11, 2018 https://doi.org/10.3892/mco.2018.1649
Pages: 219-222

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mixed adeno-neuroendocrine carcinoma (MANEC) is a rare pathological diagnosis recently acknowledged by the World Health Organization in 2010. MANEC is a neoplasm characterized by significant histological heterogeneity and is characterized by the simultaneous presence of both adenocarcinomatous and neuroendocrine differentiation; their definition includes each component found in at least 30% of the tumor. Colorectal MANEC constitutes an uncommon type of malignant tumor. The true prevalence of colorectal MANEC has not been precisely defined and published studies are limited to case reports and small case series. The aim of the present review was to accumulate the existing evidence on colorectal MANEC with special attention to the clinicopathological characteristics, management and survival rates of patients diagnosed with this malignancy. A total of 20 studies (16 case reports and 4 retrospective cohorts) reported outcomes for patients with colorectal MANEC and were finally considered eligible for analysis. The results of the present study show that patients with early stage MANEC have more favorable survival compared to those diagnosed in advanced stages. Due to its neuroendocrine nature, which is characterized by rapid progression, MANEC is diagnosed in advanced stages in the majority of cases and thus potentially explains the poor survival rates. Because of its aggressive nature and high recurrence rate, adjuvant chemotherapy constitutes a critical part of the treatment and significantly improves survival. Further larger studies are needed in order to establish guidelines for the treatment of these rare lesions.

View Figures

View References

1	Staren ED, Gould VE, Warren WH, Wool NL, Bines S, Baker J, Bonomi P, Roseman DL and Economou SG: Neuroendocrine carcinomas of the colon and rectum: A clinicopathologic evaluation. Surgery. 104:1080–1089. 1988.PubMed/NCBI
2	Komminoth P, Arnold R, Capella C, Klimstra D, Klöppel G, Solcia E and Rindi G: Neuroendocrine neoplasms of the appendix. WHO classification of tumours of the digestive system. 126–128. 2010.
3	Bosman FT, Carneiro F, Hruban RH and Theise ND: WHO Classification of Tumours of the Digestive System. 4th edition. World Health Organization; Geneva: 2010
4	Rindi G, Bordi C, La Rosa S, Solcia E and Delle Fave G: Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP): Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Dig Liver Dis. 43:S356–S360. 2011. View Article : Google Scholar : PubMed/NCBI
5	Watanabe J, Suwa Y, Ota M, Ishibe A, Masui H, Nagahori K, Tsuura Y and Endo I: Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study. Dis Colon Rectum. 59:1160–1167. 2016. View Article : Google Scholar : PubMed/NCBI
6	Jain A, Singla S, Jagdeesh KS and Vishnumurthy HY: Mixed adenoneuroendocrine carcinoma of cecum: A rare entity. J Clin Imaging Sci. 3:102013. View Article : Google Scholar : PubMed/NCBI
7	Morais M, Pinho AC, Marques A, Lopes J, Duarte A, da Silva PC, Lopes JM and Maia JC: Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception. Case Rep Surg. 2016:76843642016.PubMed/NCBI
8	Komatsubara T, Koinuma K, Miyakura Y, Horie H, Morimoto M, Ito H, Lefor AK, Sata N and Fukushima N: Endocrine cell carcinomas of the colon and rectum: A clinicopathological evaluation. Clin J Gastroenterol. 9:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
9	Gurzu S, Kadar Z, Bara T, Bara T Jr, Tamasi A, Azamfirei L and Jung I: Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: Report of two cases. World J Gastroenterol. 21:1329–1333. 2015. View Article : Google Scholar : PubMed/NCBI
10	Vanacker L, Smeets D, Hoorens A, Teugels E, Algaba R, Dehou MF, De Becker A, Lambrechts D and De Greve J: Mixed adenoneuroendocrine carcinoma of the colon: Molecular pathogenesis and treatment. Anticancer Res. 34:5517–5521. 2014.PubMed/NCBI
11	Yamauchi H, Sakurai S, Tsukagoshi R, Suzuki M, Tabe Y, Fukasawa T, Kiriyama S, Fukuchi M, Naitoh H and Kuwano H: A case of very well-differentiated adenocarcinoma with carcinoid tumor in the ascending colon. Int Surg. 99:132–136. 2014. View Article : Google Scholar : PubMed/NCBI
12	Ito H, Kudo A, Matsumura S, Ban D, Irie T, Ochiai T, Nakamura N, Tanaka S and Tanabe M: Mixed adenoneuroendocrine carcinoma of the colon progressed rapidly after hepatic rupture: Report of a case. Int Surg. 99:40–44. 2014. View Article : Google Scholar : PubMed/NCBI
13	Marando A, Dainese E, La Rosa S and Capella C: Images in endocrine pathology: Oncocytic differentiation in a mixed adenoneuroendocrine carcinoma of the colon. Endocr Pathol. 24:54–56. 2013. View Article : Google Scholar : PubMed/NCBI
14	La Rosa S, Marando A, Furlan D, Sahnane N and Capella C: Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: Insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol. 36:601–611. 2012. View Article : Google Scholar : PubMed/NCBI
15	Minaya-Bravo AM, Mahillo Garcia JC, Moreno Mendoza F, Fraguas Noguelares F and Granell J: Large cell neuroendocrine-adenocarcinona mixed tumour of colon: Collision tumour with peculiar behaviour. What do we know about these tumours? Ann Med Surg (Lond). 4:399–403. 2015. View Article : Google Scholar : PubMed/NCBI
16	Koletsa T, Beretouli E, Tziola T, Mavropoulou S and Karayannopoulou G: Neuroendocrine carcinoma in adenoma of the sigmoid. Hippokratia. 18:362–363. 2014.PubMed/NCBI
17	Jiao YF, Nakamura S, Arai T, Sugai T, Uesugi N, Habano W, Suzuki M, Tazawa H and Goukon Y: Adenoma, adenocarcinoma and mixed carcinoid-adenocarcinoma arising in a small lesion of the colon. Pathol Int. 53:457–462. 2003. View Article : Google Scholar : PubMed/NCBI
18	Jesinghaus M, Konukiewitz B, Keller G, Kloor M, Steiger K, Reiche M, Penzel R, Endris V, Arsenic R, Hermann G, et al: Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas. Mod Pathol. 30:610–619. 2017. View Article : Google Scholar : PubMed/NCBI
19	Cherbanyk F, Gassend JL, Dimitrief M, Andrejevic-Blant S, Martinet O and Pezzetta E: A rare type of colorectal cancer: mixed adeno-neuroendocrine carcinoma (MANEC). Chirurgia (Bucur). 112:152–156. 2017. View Article : Google Scholar : PubMed/NCBI
20	Shin SH, Kim SH, Jung SH, Jang JW, Kang MS, Kim SI, Kim JH and Lee JH: High-Grade Mixed adenoneuroendocrine carcinoma in the cecum: A case report. Ann Coloproctol. 33:39–42. 2017. View Article : Google Scholar : PubMed/NCBI
21	Silva JRD, Pinho RT and Furtado A: A case of a mixed adenoneuroendocrine tumor of the colon. Rev Esp Enferm Dig. 109:6732017. View Article : Google Scholar : PubMed/NCBI
22	Liu XJ, Feng JS, Xiang WY, Kong B, Wang LM, Zeng JC and Liang YF: Clinicopathological features of an ascending colon mixed adenoneuroendocrine carcinoma with clinical serosal invasion. Int J Clin Exp Pathol. 7:6395–6398. 2014.PubMed/NCBI
23	Tanaka T, Kaneko M, Nozawa H, Emoto S, Murono K, Otani K, Sasaki K, Nishikawa T, Kiyomatsu T, Hata K, et al: Diagnosis, assessment, and therapeutic strategy for colorectal mixed adenoneuroendocrine carcinoma. Neuroendocrinology. 105:426–434. 2017. View Article : Google Scholar : PubMed/NCBI
24	Eriksson B, Annibale B, Bajetta E, Mitry E, Pavel M, Platania M, Salazar R and Plöckinger U: Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society: ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Chemotherapy in patients with neuroendocrine tumors. Neuroendocrinology. 90:214–219. 2009. View Article : Google Scholar : PubMed/NCBI